NOS3, nitric oxide synthase 3, 4846

N. diseases: 706; N. variants: 39
Disease: Prostatic Neoplasms ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group BEFREE Moreover, abrogation of ERβ/eNOS function by 3β-adiol emphasizes the significance of circulating or locally produced sex steroid hormones or their metabolites in PCa biology with relevant clinical/therapeutic implications. 22052999 2011
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 GeneticVariation group LHGDN The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. 18823560 2008
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. 16458450 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 GeneticVariation group LHGDN The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. 16458450 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group LHGDN Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. 12445681 2003
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. 12445681 2003
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 Biomarker group CTD_human Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. 12429631 2002
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms 		0.350 GeneticVariation group LHGDN Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. 12195160 2002